Form D · Pharmaceuticals

Realm Therapeutics plc

London, X0 · CIK 0001718903

Offering snapshot reported Oct 25, 2017 · SEC filing

Reported sold: $20.5M
Investors reported: 8
Minimum accepted: $0
First sale: Oct 10, 2017

Fundraising history

Reported sold

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

Filed	Filing type	Reported sold	Change vs linked filing	Investors	Source
Oct 25, 2017	Amendment	$20,500,000	$0vs Oct 17, 2017	8	SEC filing
Oct 17, 2017	Initial	$20,500,000	No comparison	8	SEC filing

Offering details

Securities: Equity, Option to acquire, Security to be acquired
Exemptions: 06b
Duration over one year: No
Business combination: No

Sales commissions: $1.23M
Finders' fees: $0
Form D file number: 021-296823

Sales compensation recipients

Scroll to see all columns →

Recipient	CRD	Associated broker-dealer
MTS Securities, LLC	104059

Source: Form D, filed Oct 25, 2017. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
Name	Reported role
Joseph William Birkett	Director
Ivan Gergel	Director
Balkrishan Gill	Director
Matthew Hammond	Director
Daniel Hegglin	Director
Alex Martin	Director, Executive
Charles Spicer	Director
Marella Thorell	Director, Executive

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:

Cannon Place 78 Cannon Street
London, X0, EC4N 6AF